Cargando…

Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma

BACKGROUND: Ferroptosis is a recently recognized non-apoptotic cell death that is distinct from the apoptosis, necroptosis and pyroptosis. Considerable studies have demonstrated ferroptosis is involved in the biological process of various cancers. However, the role of ferroptosis in esophageal adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lei, Yang, Fugui, Wang, Lingwei, Dong, Lin, Huang, Zhiyuan, Wang, Guangxue, Chen, Guohan, Li, Qinchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891153/
https://www.ncbi.nlm.nih.gov/pubmed/33602233
http://dx.doi.org/10.1186/s12935-021-01821-2
_version_ 1783652646098305024
author Zhu, Lei
Yang, Fugui
Wang, Lingwei
Dong, Lin
Huang, Zhiyuan
Wang, Guangxue
Chen, Guohan
Li, Qinchuan
author_facet Zhu, Lei
Yang, Fugui
Wang, Lingwei
Dong, Lin
Huang, Zhiyuan
Wang, Guangxue
Chen, Guohan
Li, Qinchuan
author_sort Zhu, Lei
collection PubMed
description BACKGROUND: Ferroptosis is a recently recognized non-apoptotic cell death that is distinct from the apoptosis, necroptosis and pyroptosis. Considerable studies have demonstrated ferroptosis is involved in the biological process of various cancers. However, the role of ferroptosis in esophageal adenocarcinoma (EAC) remains unclear. This study aims to explore the ferroptosis-related genes (FRG) expression profiles and their prognostic values in EAC. METHODS: The FRG data and clinical information were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate cox regressions were used to identify the prognostic FRG, and the predictive ROC model was established using the independent risk factors. GO and KEGG enrichment analyses were performed to investigate the bioinformatics functions of significantly different genes (SDG) of ferroptosis. Additionally, the correlations of ferroptosis and immune cells were assessed through the single-sample gene set enrichment analysis (ssGSEA) and TIMER database. Finally, SDG were verified in clinical EAC specimens and normal esophageal mucosal tissues. RESULTS: Twenty-eight significantly different FRG were screened from 78 EAC and 9 normal tissues. Enrichment analyses showed these SDG were mainly related to the iron-related pathways and metabolisms of ferroptosis. Gene network demonstrated the TP53, G6PD, NFE2L2 and PTGS2 were the hub genes in the biology of ferroptosis. Cox regression analyses demonstrated four FRG (CARS1, GCLM, GLS2 and EMC2) had prognostic values for overall survival (OS) (all P < 0.05). ROC curve showed better predictive ability using the risk score (AUC = 0.744). Immune cell enrichment analysis demonstrated that the types of immune cells and their expression levels in the high-risk group were significant different with those in the low-risk group (all P < 0.05). The experimental results confirmed the ALOX5, NOX1 were upregulated and the MT1G was downregulated in the EAC tissues compared with the normal esophageal mucosal tissues (all P < 0.05). CONCLUSIONS: We identified differently expressed ferroptosis-related genes that may involve in EAC. These genes have significant values in predicting the patients’ OS and targeting ferroptosis may be an alternative for therapy. Further studies are necessary to verify these results of our study.
format Online
Article
Text
id pubmed-7891153
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78911532021-02-22 Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma Zhu, Lei Yang, Fugui Wang, Lingwei Dong, Lin Huang, Zhiyuan Wang, Guangxue Chen, Guohan Li, Qinchuan Cancer Cell Int Primary Research BACKGROUND: Ferroptosis is a recently recognized non-apoptotic cell death that is distinct from the apoptosis, necroptosis and pyroptosis. Considerable studies have demonstrated ferroptosis is involved in the biological process of various cancers. However, the role of ferroptosis in esophageal adenocarcinoma (EAC) remains unclear. This study aims to explore the ferroptosis-related genes (FRG) expression profiles and their prognostic values in EAC. METHODS: The FRG data and clinical information were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate cox regressions were used to identify the prognostic FRG, and the predictive ROC model was established using the independent risk factors. GO and KEGG enrichment analyses were performed to investigate the bioinformatics functions of significantly different genes (SDG) of ferroptosis. Additionally, the correlations of ferroptosis and immune cells were assessed through the single-sample gene set enrichment analysis (ssGSEA) and TIMER database. Finally, SDG were verified in clinical EAC specimens and normal esophageal mucosal tissues. RESULTS: Twenty-eight significantly different FRG were screened from 78 EAC and 9 normal tissues. Enrichment analyses showed these SDG were mainly related to the iron-related pathways and metabolisms of ferroptosis. Gene network demonstrated the TP53, G6PD, NFE2L2 and PTGS2 were the hub genes in the biology of ferroptosis. Cox regression analyses demonstrated four FRG (CARS1, GCLM, GLS2 and EMC2) had prognostic values for overall survival (OS) (all P < 0.05). ROC curve showed better predictive ability using the risk score (AUC = 0.744). Immune cell enrichment analysis demonstrated that the types of immune cells and their expression levels in the high-risk group were significant different with those in the low-risk group (all P < 0.05). The experimental results confirmed the ALOX5, NOX1 were upregulated and the MT1G was downregulated in the EAC tissues compared with the normal esophageal mucosal tissues (all P < 0.05). CONCLUSIONS: We identified differently expressed ferroptosis-related genes that may involve in EAC. These genes have significant values in predicting the patients’ OS and targeting ferroptosis may be an alternative for therapy. Further studies are necessary to verify these results of our study. BioMed Central 2021-02-18 /pmc/articles/PMC7891153/ /pubmed/33602233 http://dx.doi.org/10.1186/s12935-021-01821-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Zhu, Lei
Yang, Fugui
Wang, Lingwei
Dong, Lin
Huang, Zhiyuan
Wang, Guangxue
Chen, Guohan
Li, Qinchuan
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title_full Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title_fullStr Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title_full_unstemmed Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title_short Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
title_sort identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891153/
https://www.ncbi.nlm.nih.gov/pubmed/33602233
http://dx.doi.org/10.1186/s12935-021-01821-2
work_keys_str_mv AT zhulei identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT yangfugui identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT wanglingwei identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT donglin identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT huangzhiyuan identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT wangguangxue identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT chenguohan identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma
AT liqinchuan identificationtheferroptosisrelatedgenesignatureinpatientswithesophagealadenocarcinoma